#1 Clinical Trials Search in Europe

Dexamethasone Sodium Phosphate

Dexamethasone sodium phosphate is a corticosteroid medication being studied in various clinical trials for its potential benefits in treating different medical conditions. These trials are exploring its use in areas such as neurological disorders, pain management, and postoperative care. Researchers are investigating different administration methods and combinations with other drugs to optimize its therapeutic effects while minimizing side effects.

Table of Contents

What is Dexamethasone Sodium Phosphate?

Dexamethasone Sodium Phosphate is a powerful corticosteroid medication used to treat various medical conditions. It’s a synthetic version of hormones naturally produced by your adrenal glands[1]. This drug is known by several names, including:

  • Dexamethasone
  • DSP
  • Dex 21P
These different names all refer to the same medication[2].

Medical Conditions Treated

Dexamethasone Sodium Phosphate is used to treat a wide range of medical conditions due to its anti-inflammatory and immunosuppressive properties. Some of the conditions it’s used for include:

  • Ataxia Telangiectasia (A-T): A rare genetic disorder affecting the nervous system. Dexamethasone is being studied to improve neurological symptoms in patients with A-T[3].
  • Multiple Myeloma: A type of blood cancer. Dexamethasone is often used in combination with other drugs to treat this condition[4].
  • Asthma: It’s used to treat asthma exacerbations (sudden worsening of asthma symptoms) in children[5].
  • COVID-19: Dexamethasone has shown promise in reducing mortality in COVID-19 patients requiring oxygen therapy[1].
  • Sciatica: It’s being studied for treating acute disc herniation-induced sciatica (pain that radiates along the sciatic nerve)[6].
  • Post-operative inflammation: It’s used to reduce inflammation after cataract surgery[7].

How is it Administered?

Dexamethasone Sodium Phosphate can be administered in several ways, depending on the condition being treated:

  • Oral: Taken by mouth as tablets or liquid[1].
  • Intravenous (IV): Injected directly into a vein[6].
  • Intravitreal: Injected directly into the eye for certain eye conditions[2].
  • Encapsulated in red blood cells: A special formulation where the drug is placed inside the patient’s own red blood cells before being reinfused. This method is being studied for conditions like Ataxia Telangiectasia[3].

Current Clinical Trials

Several clinical trials are currently underway to explore new uses and formulations of Dexamethasone Sodium Phosphate:

  • A study comparing dexamethasone to prednisolone (another corticosteroid) in COVID-19 patients[1].
  • Trials investigating the use of dexamethasone encapsulated in red blood cells (called EryDex) for treating Ataxia Telangiectasia[3].
  • Research on using dexamethasone for post-operative inflammation in cataract surgery patients[7].
  • Studies on the effectiveness of dexamethasone in treating pediatric asthma exacerbations[5].

Potential Side Effects

Like all medications, Dexamethasone Sodium Phosphate can cause side effects. Some potential side effects include:

  • Changes in blood sugar levels
  • Mood swings or behavioral changes
  • Changes in appetite
  • Increased sweating
  • Headache
  • Nausea or vomiting

It’s important to discuss potential side effects with your healthcare provider before starting treatment[5].

Special Formulations

Researchers are exploring innovative ways to deliver Dexamethasone Sodium Phosphate to improve its effectiveness and reduce side effects:

  • EryDex: This is a special formulation where dexamethasone is encapsulated within the patient’s own red blood cells. This method is being studied for treating Ataxia Telangiectasia and may help deliver the drug more effectively while reducing side effects[3].
  • Iontophoretic delivery: This method uses a small electrical current to help deliver the drug through the eye for treating post-operative inflammation after cataract surgery[7].

These special formulations are still being studied and are not yet widely available for general use. They represent exciting potential advancements in how we use this powerful medication to treat various conditions.

Aspect Details
Main Conditions Studied Ataxia Telangiectasia, Diabetic Macular Edema, Asthma Exacerbations, Chronic Postoperative Pain
Administration Methods Intravenous infusion, Intravitreal injection, Oral administration, Nerve blocks, Encapsulated in autologous erythrocytes
Key Outcome Measures Neurological symptoms improvement, Macular edema reduction, Pain management efficacy, Duration of analgesia
Potential Benefits Improved neurological function, Better postoperative pain control, Reduced inflammation, Extended drug action
Safety Considerations Blood sugar levels, Wound healing, Steroid-related side effects
Innovative Approaches Combination with other drugs, Use of drug delivery systems (e.g., erythrocyte encapsulation)

FAQ

  • What is dexamethasone sodium phosphate? Dexamethasone sodium phosphate is a corticosteroid medication with anti-inflammatory and immunosuppressive properties. It is being studied in clinical trials for various medical conditions due to its potential therapeutic effects.
  • What conditions are being studied using dexamethasone sodium phosphate? Clinical trials are exploring its use in conditions such as ataxia telangiectasia, diabetic macular edema, asthma exacerbations, chronic postoperative pain, and as part of nerve blocks for pain management in surgeries.
  • How is dexamethasone sodium phosphate administered in these trials? Administration methods vary depending on the study, including intravenous infusion, intravitreal injection, oral administration, and as part of nerve blocks. Some trials are also exploring its use when encapsulated in autologous erythrocytes.
  • What are some potential benefits of dexamethasone sodium phosphate being studied? Potential benefits being investigated include improved neurological symptoms in ataxia telangiectasia, reduced macular edema after cataract surgery in diabetics, better pain management after surgeries, and prolonged analgesia when used in nerve blocks.
  • Are there any side effects or risks associated with dexamethasone sodium phosphate? While specific side effects can vary depending on the condition and administration method, common concerns include increased blood sugar levels, poor wound healing, and other steroid-related side effects. Researchers are working to optimize dosing and delivery methods to minimize these risks.

Ongoing Clinical Trials on Dexamethasone Sodium Phosphate

  • Comparing the effectiveness of nepafenac and dexamethasone sodium phosphate for treating eye inflammation after cataract surgery

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • A Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

    Recruiting

    2 1 1 1
    Investigated drugs:
    Belgium France Ireland Italy Poland Spain

  • Comparing Two Doses of Dexamethasone to Improve Quality of Life in Patients 60 Years and Older Having Total Hip Replacement Surgery

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Comparing CT-P44 and Darzalex Faspro with lenalidomide and dexamethasone in patients with refractory or relapsed multiple myeloma

    Recruiting

    3 1 1 1
    Investigated drugs:
    Poland Spain

  • Study Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark Finland France +11

  • Study on the Effects of Dexamethasone in Adults with Acute Respiratory Failure Due to Infections, Including COVID-19

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Effectiveness and Safety of Bortezomib and Daratumumab for Patients with Primary Plasma Cell Leukemia

    Recruiting

    2 1 1 1
    Investigated drugs:
    Greece

  • Study Comparing Inotuzumab Ozogamicin to Drug Combination for Children with High-Risk Relapsed B-cell Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark Finland France +10

  • Study of Linvoseltamab in Adults with Relapsed or Refractory Multiple Myeloma

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium Spain

  • Study on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Estonia France Italy The Netherlands Portugal +3

Glossary

  • Ataxia Telangiectasia: A rare genetic disorder that affects the nervous system, immune system, and other body systems. It is characterized by progressive difficulty with coordination and movement.
  • Macular Edema: Swelling or thickening of the macula, the part of the retina responsible for detailed central vision. It can occur as a complication of various eye conditions, including diabetes.
  • Paravertebral Nerve Block: A type of regional anesthesia where local anesthetic is injected near the spine to block nerve signals from specific areas of the body.
  • Erythrocytes: Red blood cells. In some studies, dexamethasone is encapsulated within a patient's own red blood cells for delivery.
  • Chronic Postoperative Pain: Pain that persists for three months or longer after a surgical procedure.
  • International Cooperative Ataxia Rating Scale (ICARS): A clinical rating scale used to assess and quantify ataxia, which is a lack of muscle control or coordination of voluntary movements.
  • Intravitreal: Administered into the vitreous cavity of the eye.
  • Visual Analogue Scale (VAS): A measurement instrument for subjective characteristics or attitudes that cannot be directly measured, often used to assess pain intensity.

References

  1. https://clinicaltrials.gov/study/NCT04765371
  2. https://clinicaltrials.gov/study/NCT01030601
  3. https://clinicaltrials.eu/trial/study-on-the-effects-of-erydex-dexamethasone-sodium-phosphate-for-children-aged-6-9-with-ataxia-telangiectasia/
  4. https://clinicaltrials.gov/study/NCT02586038
  5. https://clinicaltrials.gov/study/NCT02192827
  6. https://clinicaltrials.gov/study/NCT00516009
  7. https://clinicaltrials.gov/study/NCT02571556